Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeXtGen Biologics
AddedFeb 16, 2024
UpdatedJun 18, 2026
NeXtGen Biologics

NeXtGen Biologics

Seed

NeXtGen Biologics, a Florida-based medical device company, innovates ECM products since 2014.

HQ
Alachua, FL, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded in 2014 and headquartered in Alachua, Florida, NeXtGen Biologics is a pioneering medical device company focused on developing novel extracellular matrix (ECM) products. The company's core mission is to innovate and advance ECM technologies to improve patient outcomes in various medical fields. NeXtGen Biologics offers a range of ECM-based products designed to support tissue repair and regeneration, targeting markets in healthcare and medical manufacturing.

Notable affiliated individuals include the company's founders, whose expertise drives the innovation at NeXtGen Biologics. The company has attracted significant interest from investors in the medical device sector. Key achievements include the development of a robust pipeline of ECM technologies and securing multiple patents. NeXtGen Biologics has made a substantial impact on the medical device industry by providing advanced solutions that enhance the healing process and improve patient care.

NeXtGen Biologics - Similar Companies

ECM Therapeutics logo

ECM Therapeutics

Exogenesis logo

Exogenesis

Nexgen Medical Systems logo

Nexgen Medical Systems

Direct Biologics logo

Direct Biologics

42Bio logo

42Bio

42bio.com

Circle Biologics logo

Circle Biologics

EndoCellutions logo

EndoCellutions

endocellutions.com

BiotechInnova logo

BiotechInnova

biotechinnova.com

BioRegenx logo

BioRegenx

bioregenx.com

NXT Biomedical logo

NXT Biomedical

nxtbiomedical.com

GeniPhys logo

GeniPhys

geniphys.com

TissueForm logo

TissueForm

tissueforminc.com

Next Frontier Biosciences logo

Next Frontier Biosciences

Endogena Therapeutics logo

Endogena Therapeutics

Axogen logo

Axogen

axogeninc.com

NeXtGen Biologics - Quick Facts

Who are NeXtGen Biologics' competitors?

Companies similar to NeXtGen Biologics include ECM Therapeutics, Exogenesis, Nexgen Medical Systems and Direct Biologics.

When was NeXtGen Biologics founded?

NeXtGen Biologics was founded in 2014.

Where is NeXtGen Biologics' headquarters located?

NeXtGen Biologics' headquarters is located in Alachua, FL, US.

When was NeXtGen Biologics' last funding round?

NeXtGen Biologics' most recent funding round was for $100k (USD) in August 2020.

How much has NeXtGen Biologics raised to-date?

As of Aug 14, 2020, NeXtGen Biologics has raised a total of $1.9M (USD).

How many employees does NeXtGen Biologics have?

NeXtGen Biologics has 9 employees as of Feb 5, 2024.

NeXtGen Biologics - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 11 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified